ResMed (NYSE: RMD) has outperformed the market over the past 10 years by 2.9% on an annualized basis producing an average annual return of 16.12%. Currently, ResMed has a market capitalization of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results